Literature DB >> 4451350

In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin.

D Rifkind, E D Crowder, R N Hyland.   

Abstract

Rifampin was shown in vitro to decrease the amphotericin B minimal inhibitory concentrations of all of 10 strains of Coccidioides immitis tested. These decreases ranged from two- to fourfold and occurred with rifampin concentrations of 10 to 40 mug/ml. Rifampin alone was without effect.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4451350      PMCID： PMC444736          DOI： 10.1128/AAC.6.6.783

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Coccidioidomycosis. The need for careful evaluation of the clinical pattern and anatomical lesions.

Authors:  W A WINN
Journal:  Arch Intern Med       Date:  1960-10

2.  Coccidioidal pulmonary cavitation.

Authors:  L HYDE
Journal:  Am J Med       Date:  1958-12       Impact factor: 4.965

3.  Effect of rifampicin on delayed-hypersensitivity reactions.

Authors:  G G Grassi; E Pozzi
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

4.  Levels of rifampin in cerebrospinal fluid.

Authors:  J H Ostrow
Journal:  Chest       Date:  1973-04       Impact factor: 9.410

5.  Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

Authors:  L Verbist; A Gyselen
Journal:  Am Rev Respir Dis       Date:  1968-12

6.  Pharmacokinetics of intrathecally administered amphotericin B.

Authors:  A J Atkinson; D D Bindschadler
Journal:  Am Rev Respir Dis       Date:  1969-06

7.  Rifampin. Levels in serum and saliva and effect on the meningococcal carrier state.

Authors:  L F Devine; D P Johnson; C R Hagerman; W E Pierce; S L Rhode; R O Peckinpaugh
Journal:  JAMA       Date:  1970-11-09       Impact factor: 56.272

8.  Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.

Authors:  A Vall-Spinosa; W Lester; T Moulding; P T Davidson; J K McClatchy
Journal:  N Engl J Med       Date:  1970-09-17       Impact factor: 91.245

9.  Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum.

Authors:  G S Kobbayashi; G Medoff; D Schlessinger; C N Kwan; W E Musser
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

10.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205
View more
  9 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans.

Authors:  N K Fujita; J E Edwards
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

4.  Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.

Authors:  M Huppert; D Pappagianis; S H Sun; I Gleason-Jordan; M S Collins; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Sensitivity of Scopulariopsis brevicaulis to some antimicrobial agents.

Authors:  A S Sekhon
Journal:  Mycopathologia       Date:  1975-12-31       Impact factor: 2.574

6.  Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

7.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

8.  In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.

Authors:  M R Moody; V M Young; M J Morris; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

9.  Synergistic action of amphotericin B and rifampin against Rhizopus species.

Authors:  J C Christenson; I Shalit; D F Welch; A Guruswamy; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.